Pallas Capital Advisors LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1862282
BRAINTREE, MA
Position in XERS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$88,323
+$23,822 QoQ
Shares Held
11,152
+0.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#177
of 238 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $4,121,079 across 10 Drug Manufacturers - Specialty & Generic names. XERS ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
9,265 | $1,561,523 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,227 | $1,206,655 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,667 | $490,304 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
73,996 | $311,523 | |
| 5 | ZTS |
Zoetis Inc.
|
4,142 | $297,644 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
10,059 | $100,590 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
11,152 | $88,323 | |
| 8 | ORGO |
Organogenesis Holdings Inc.
|
15,150 | $36,814 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,323 | 11,152 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $64,501 | 11,121 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $86,373 | 11,003 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $89,759 | 11,027 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $51,393 | 11,005 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $84,233 | 15,343 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||